• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助化疗对可手术乳腺癌患者血液淋巴细胞群的影响。两种治疗方法的比较。

Influence of adjuvant chemotherapy on the blood lymphocyte population in operable breast carcinoma. Comparison between two types of treatments.

作者信息

Strender L E, Petrini B, Blomgren H, Wasserman J, Wallgren A, Baral E

出版信息

Acta Radiol Oncol. 1982;21(4):217-24. doi: 10.3109/02841868209134009.

DOI:10.3109/02841868209134009
PMID:6293264
Abstract

The influence on the blood lymphocyte population of two types of postoperative adjuvant chemotherapy regimes given to patients with large breast tumors or involved axillary lymph nodes have been examined. Cyclic treatment with a combination of chlorambucil, methotrexate and 5-fluorouracil was more myelotoxic and required more extensive dose reductions than treatment with cyclophosphamide, methotrexate and 5-fluorouracil with the dosage used. Both treatments reduced the size of the blood lymphocyte population and changed its cellular composition, as defined by rosette tests, to approximately the same extent. Response of the lymphocytes to specific and non-specific mitogens were also affected to approximately the same extent. A comparison of the clinical value between the two treatments has not yet been performed.

摘要

已对给予患有大乳腺肿瘤或腋窝淋巴结受累患者的两种术后辅助化疗方案对血液淋巴细胞群体的影响进行了研究。与使用环磷酰胺、甲氨蝶呤和5-氟尿嘧啶的常规剂量治疗相比,苯丁酸氮芥、甲氨蝶呤和5-氟尿嘧啶联合的循环治疗对骨髓的毒性更大,需要更广泛地降低剂量。两种治疗均减小了血液淋巴细胞群体的规模,并改变了其细胞组成(通过玫瑰花结试验定义),程度大致相同。淋巴细胞对特异性和非特异性有丝分裂原的反应也受到大致相同程度的影响。尚未对两种治疗的临床价值进行比较。

相似文献

1
Influence of adjuvant chemotherapy on the blood lymphocyte population in operable breast carcinoma. Comparison between two types of treatments.辅助化疗对可手术乳腺癌患者血液淋巴细胞群的影响。两种治疗方法的比较。
Acta Radiol Oncol. 1982;21(4):217-24. doi: 10.3109/02841868209134009.
2
Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.他莫昔芬与联合化疗作为绝经后乳腺癌女性的辅助治疗
Recent Results Cancer Res. 1984;96:197-203. doi: 10.1007/978-3-642-82357-2_25.
3
Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.可手术乳腺癌的辅助化疗:环磷酰胺、甲氨蝶呤和氟尿嘧啶与苯丁酸氮芥、甲氨蝶呤和氟尿嘧啶的对比——瑞士临床癌症研究组SAKK 27/82试验的11年结果
J Clin Oncol. 1997 Jul;15(7):2502-9. doi: 10.1200/JCO.1997.15.7.2502.
4
Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.在有1至3个腋窝淋巴结阳性的乳腺癌患者中,比较甲氨蝶呤和氟尿嘧啶联合或不联合环磷酰胺的辅助化疗效果。
J Natl Cancer Inst. 1993 May 19;85(10):812-7. doi: 10.1093/jnci/85.10.812.
5
Combination chemotherapy as an adjuvant treatment in operable breast cancer.联合化疗作为可手术乳腺癌的辅助治疗方法。
N Engl J Med. 1976 Feb 19;294(8):405-10. doi: 10.1056/NEJM197602192940801.
6
Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Lancet. 1984 Jun 9;1(8389):1256-60.
7
Adjuvant chemotherapy for node-negative breast cancer patients.淋巴结阴性乳腺癌患者的辅助化疗。
Recent Results Cancer Res. 1989;115:175-9. doi: 10.1007/978-3-642-83337-3_25.
8
Impact of irradiation of residual breast on adjuvant chemotherapy dose intensity.残留乳腺照射对辅助化疗剂量强度的影响。
Am J Clin Oncol. 1993 Feb;16(1):58-60. doi: 10.1097/00000421-199302000-00015.
9
West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes.西米德兰兹郡肿瘤协会对可手术乳腺癌辅助化疗的试验:中位随访7年后的结果。II. 腋窝淋巴结未受累的患者。
Br J Cancer. 1989 Dec;60(6):919-24. doi: 10.1038/bjc.1989.390.
10
Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B.绝经前和绝经后高危乳腺癌患者的辅助治疗。丹麦乳腺癌协作组77-B和82-B试验的现状。
Acta Oncol. 1988;27(6A):691-7. doi: 10.3109/02841868809091771.

引用本文的文献

1
The impact of different modalities of chemoradiation therapy and chemotherapy regimens on lymphopenia in patients with locally advanced non-small cell lung cancer.不同放化疗方式及化疗方案对局部晚期非小细胞肺癌患者淋巴细胞减少症的影响。
Transl Lung Cancer Res. 2024 Jun 30;13(6):1190-1200. doi: 10.21037/tlcr-24-60. Epub 2024 Jun 27.
2
Modeling of radiation effects to immune system: a review.辐射对免疫系统影响的建模:综述
J Korean Phys Soc. 2022;81(11):1013-1019. doi: 10.1007/s40042-022-00574-z. Epub 2022 Aug 8.
3
Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer.
原发性乳腺癌化疗后的淋巴细胞耗竭与再增殖
Breast Cancer Res. 2016 Jan 26;18(1):10. doi: 10.1186/s13058-015-0669-x.
4
Immune functions and the prognosis of patients with solid tumours.实体瘤患者的免疫功能与预后
Cancer Immunol Immunother. 1985;20(1):38-42. doi: 10.1007/BF00199771.